Extreme hypocalcaemia and hyperparathyroidism following denosumab. Is this drug safe in chronic kidney disease?

Statistics

Hipocalcemia e hiperparatiroidismo extremos tras denosumab. ¿Es seguro este fármaco en la enfermedad renal crónica?

Ana E. Sirventa, Ricardo Enríqueza, María Sáncheza, César Gonzáleza, Isabel Millána, Francisco Amorósa

a Servicio de Nefrología, Hospital General Universitario de Elche, Alicante,

Read

16959

Times
was read the article

2863

Total PDF

14096

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:10.3265/Nefrologia.pre2014.Mar.12383

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	102	51	153
2024 October	114	45	159
2024 September	110	39	149
2024 August	121	66	187
2024 July	114	38	152
2024 June	130	44	174
2024 May	137	45	182
2024 April	122	33	155
2024 March	108	32	140
2024 February	105	32	137
2024 January	87	28	115
2023 December	76	27	103
2023 November	125	41	166
2023 October	101	40	141
2023 September	85	35	120
2023 August	84	33	117
2023 July	145	23	168
2023 June	185	20	205
2023 May	183	38	221
2023 April	110	14	124
2023 March	126	36	162
2023 February	84	23	107
2023 January	107	41	148
2022 December	92	38	130
2022 November	89	28	117
2022 October	124	52	176
2022 September	92	44	136
2022 August	80	44	124
2022 July	75	44	119
2022 June	70	37	107
2022 May	74	34	108
2022 April	95	56	151
2022 March	71	44	115
2022 February	85	40	125
2022 January	123	37	160
2021 December	94	48	142
2021 November	112	40	152
2021 October	199	51	250
2021 September	124	44	168
2021 August	96	36	132
2021 July	131	43	174
2021 June	116	39	155
2021 May	79	43	122
2021 April	224	49	273
2021 March	158	43	201
2021 February	147	16	163
2021 January	120	29	149
2020 December	114	26	140
2020 November	120	15	135
2020 October	74	19	93
2020 September	126	19	145
2020 August	87	22	109
2020 July	125	18	143
2020 June	102	44	146
2020 May	144	24	168
2020 April	94	19	113
2020 March	98	28	126
2020 February	146	26	172
2020 January	130	25	155
2019 December	157	40	197
2019 November	165	29	194
2019 October	138	27	165
2019 September	172	18	190
2019 August	156	21	177
2019 July	168	25	193
2019 June	133	22	155
2019 May	137	30	167
2019 April	166	41	207
2019 March	89	24	113
2019 February	63	22	85
2019 January	77	29	106
2018 December	138	52	190
2018 November	156	17	173
2018 October	132	16	148
2018 September	146	15	161
2018 August	101	17	118
2018 July	106	15	121
2018 June	100	21	121
2018 May	107	18	125
2018 April	132	7	139
2018 March	107	8	115
2018 February	94	6	100
2018 January	105	5	110
2017 December	90	9	99
2017 November	115	11	126
2017 October	101	11	112
2017 September	94	7	101
2017 August	121	13	134
2017 July	129	16	145
2017 June	122	17	139
2017 May	128	14	142
2017 April	136	40	176
2017 March	97	19	116
2017 February	114	16	130
2017 January	102	13	115
2016 December	115	10	125
2016 November	137	9	146
2016 October	198	16	214
2016 September	234	8	242
2016 August	236	11	247
2016 July	278	10	288
2016 June	186	0	186
2016 May	199	0	199
2016 April	144	0	144
2016 March	118	0	118
2016 February	149	0	149
2016 January	138	0	138
2015 December	136	0	136
2015 November	114	0	114
2015 October	122	0	122
2015 September	116	0	116
2015 August	93	0	93
2015 July	125	0	125
2015 June	74	0	74
2015 May	86	0	86
2015 April	13	0	13

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter